Form 8-K - Current report:
SEC Accession No. 0001558370-23-010139
Filing Date
2023-05-17
Accepted
2023-05-17 16:30:21
Documents
12
Period of Report
2023-05-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K edit-20230511x8k.htm   iXBRL 8-K 34586
  Complete submission text file 0001558370-23-010139.txt   152789

Data Files

Seq Description Document Type Size
2 EX-101.SCH edit-20230511.xsd EX-101.SCH 3150
3 EX-101.LAB edit-20230511_lab.xml EX-101.LAB 15240
4 EX-101.PRE edit-20230511_pre.xml EX-101.PRE 9831
6 EXTRACTED XBRL INSTANCE DOCUMENT edit-20230511x8k_htm.xml XML 4672
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 23932166
SIC: 2836 Biological Products, (No Diagnostic Substances)